ABOS
Price
$2.24
Change
+$0.01 (+0.45%)
Updated
Sep 25 closing price
Capitalization
161.99M
50 days until earnings call
Intraday BUY SELL Signals
GNLX
Price
$2.48
Change
+$0.05 (+2.06%)
Updated
Sep 25 closing price
Capitalization
112.21M
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABOS vs GNLX

ABOS vs GNLX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABOS vs. GNLX commentary
Sep 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and GNLX is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ABOSGNLX
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 27, 2026
Stock price -- (ABOS: $2.24 vs. GNLX: $2.48)
Brand notoriety: ABOS and GNLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 62% vs. GNLX: 49%
Market capitalization -- ABOS: $161.99M vs. GNLX: $112.21M
ABOS [@Biotechnology] is valued at $161.99M. GNLX’s [@Biotechnology] market capitalization is $112.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green while GNLX’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • GNLX’s FA Score: 0 green, 5 red.
According to our system of comparison, ABOS is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while GNLX’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 6 bearish.
  • GNLX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -15.47% price change this week, while GNLX (@Biotechnology) price change was -1.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 16, 2026.

GNLX is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABOS
Daily Signal:
Gain/Loss:
GNLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VTHR339.231.64
+0.49%
Vanguard Russell 3000 ETF (VTHR)
MYLD32.480.13
+0.39%
Cambria Micro and SmallCap Shareholder Yield ETF (MYLD)
TALV28.400.04
+0.16%
Transamerica Large Value Active ETF
BKUI49.580.02
+0.04%
BNY Mellon Ultra Short Income ETF (BKUI)
KTUP4.72-0.30
-5.98%
T-REX 2X Long KTOS Daily Target ETF (KTUP)

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CCXI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CCXI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+0.22%
CCXI - ABOS
48%
Loosely correlated
+1.64%
NKTX - ABOS
42%
Loosely correlated
-3.51%
RCKT - ABOS
42%
Loosely correlated
-3.53%
EDIT - ABOS
40%
Loosely correlated
-6.18%
SANA - ABOS
39%
Loosely correlated
-0.51%
More

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with BNTC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then BNTC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
+2.06%
BNTC - GNLX
41%
Loosely correlated
-0.52%
MGTX - GNLX
34%
Loosely correlated
-1.27%
ABOS - GNLX
34%
Loosely correlated
+0.22%
IKT - GNLX
32%
Poorly correlated
-1.90%
FTH - GNLX
32%
Poorly correlated
-3.61%
More